EnvisionRheumat

14/14: Understanding the role of autoantibodies in IIMs is crucial for effective diagnosis & management. 🩺Stay tuned for more updates on this rapidly evolving field! ⚡

13/14 Re-defining IIM into distinct endotypes could offer new insights into the heterogeneity of this complex disease & inform personalized treatment strategies. 🧬

1/14: 🔬 Idiopathic inflammatory myopathies (IIMs) are a diverse group of autoimmune diseases characterized by chronic muscle inflammation.

1/12 🧫🔬 Exploring methods for IgE antibody testing: Singleplex vs. Multiplex ImmunoAssays! Dive into the latest insights from the Molecular Allergology User Guide 2.0. #AllergyTwitter #IgETesting

10/10 📊 Key Takeaways: Personalize treatment Regular monitoring crucial Multi-disciplinary approach essential New criteria aid research standardization Stay updated on evolving management strategies! #APS #Rheumatology

9/10 🔍 Special Scenarios: Check baseline PT pre-VKA POC INR only after 3 paired results match lab Consider anti-Xa monitoring Careful with heparinoids

5/10 🚨 CAPS Management: Triple therapy essential: IV heparin (monitor anti-Xa NOT APTT) High-dose steroids IVIG/plasmapheresis Consider eculizumab in refractory cases